| Literature DB >> 34886070 |
Beatriz Vallina Acha1,2, Estrella Durá Ferrandis1, Mireia Ferri Sanz2, Maite Ferrando García2.
Abstract
INTRODUCTION: Engagement and co-production in healthcare research and innovation are crucial for delivering person-centred interventions in underserved communities, but the knowledge of effective strategies to target this population is still vague, limiting the provision of person-centred care. Our research aimed to identify essential knowledge to foster engagement and co-production.Entities:
Keywords: co-production; engagement; hard-to-reach; health communication; participatory research; recruitment
Mesh:
Year: 2021 PMID: 34886070 PMCID: PMC8656837 DOI: 10.3390/ijerph182312334
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Search strategy and result diagram.
Inclusion and exclusion criteria.
| Inclusion Criteria | Exclusion Criteria |
|---|---|
|
Peer-reviewed (articles, PhD dissertations…) Primary study Qualitative study Mixed method study From 2008 to 2018 (economic crisis and partial recovery) High-income countries (transferability of results) Adult populations In situations of psycho-social vulnerability CASP ≥ 8 |
Conflict of interest declared Non-peer reviewed (e.g., reports) Systematic reviews and meta-synthesis Quantitative studies Before 2008 or after 2019 Low- and medium-income countries Focused on children and teenagers; minors Focused on older persons |
Studies included, characteristics, and ethical considerations.
| Year | Type of Study | Ethical Statement and Considerations | ||
|---|---|---|---|---|
| a | 2010 | Scientific article | Approved by Thames Valley multi-centre research ethics committee. | |
| b | 2016 | Scientific article | Approved by the Health Research Ethics Board at the University of Alberta. | |
| c | 2016 | Scientific article | Approved by Institutional Review Boards at the University of California. Ethics issues widely discussed within the study. | |
| d | 2016 | Scientific article |
| The study did not need approval of the ethical review board according to the Dutch Medical Research Involving Human Subjects Act (WMO); only (non-intervention) studies with a high burdenfor patients require a review. |
| e | 2012 | Scientific article | Ethics approval was gained from the Joint UCL/UCLH Committees on the Ethics of Human Research. | |
| F | 2009 | Scientific article |
| AN explicit ethics statement was not found. |
| g | 2012 | Scientific article | Approved by the Jackson State University Mississippi and the Indiana University Kokomo Institutional Review Boards. | |
| h | 2011 | Scientific article | Approved by the Eastern Multi-Centre Research Ethics Committee. | |
| i | 2012 | Scientific article | Approved by the ethics committee of the University of Auckland, through which the research was undertaken. | |
| j | 2017 | Scientific article | Approved by the James Cook University Ethics Committee, Queensland University, and La Trobe University Faculty of Health Sciences Human Ethics Committee. | |
| k | 2008 | Scientific article | Ethical considerations were discussed and detailed; approval procedures were not explicitly stated. | |
| l | 2013 | Scientific article |
| The study did not explicit state the ethical procedures and approval. |
| m | 2015 | Scientific article |
| The study did not explicit state the ethical procedures and approval: each project seems to have obtained the ethical approval from its respective committee. |
| n | 2015 | Scientific article | ? | The study did not explicit state the ethical procedures and approval: it seemed to depend on the clinical trial registry and approval. |
| o | 2014 | Scientific article |
| The study did not explicit state the ethical procedures and approval, but offered detailed information about data and research integrity and participatory procedures. |
| p | 2009 | Scientific article | Approved by the appropriate institutional review boards (National Institute of Mental Health and the HIV Center for Clinical and Behavioral Studies). | |
| q | 2014 | Scientific article | This qualitative study formed part of the ‘Evidence base for Patient and public Involvement in Clinical trials’(EPIC) project. The National Research Ethics Service (NRES) advised that EPIC did not require NRES ethics approval; we therefore sought and obtained a favourable ethical opinion from the University of Liverpool Research Ethics Committee. | |
| r | 2015 | Scientific article |
| As this was an independent consultation exercise on behalf of the London Sexual Health Programme, ethical approval was not required. |
| s | 2015 | Scientific article | Although the ethical approval was not explicit, a detailed section on quality procedures and ethical considerations was included. | |
| t | 2016 | Scientific article | The Albert Einstein College of Medicine′s Institutional Review Board approved the study. | |
| u | 2013 | Scientific article | The regional committee for medical ethics in Central Norway approved the study, and it was registered with the Norwegian Data Inspectorate. | |
| v | 2017 | Scientific article | The study was approved by the institutional review board at the authors’ institution (Department of Health Education and Behavior, University of Florida). | |
| x | 2016 | Scientific article | Ethical approval for this project was granted by the Aboriginal Health and Medical Research Council. | |
Thematic coverage and sample of the papers included in the meta-synthesis.
| Year | Geographical | Sample | Social Factors to Be Considered and Rationale for Their Inclusion | Focus | |
|---|---|---|---|---|---|
| a | 2010 | UK | 21 patients | The paper aimed at reflecting the maximum variety in age, sex, ethnicity, health literacy, IT literacy, stage, severity of condition, presence of other illnesses, and extent of family support. | PATIENT |
| b | 2016 | CANADA | 32 female HCPs and 2 male HCPs; 8 non-specified; 48 nurses; 8 patients, gender non-specified | Persons with HIV and nurses. Nurse mentees worked in a range of clinical areas, including community or public health, sexually transmitted infection clinics, prisons, long-term care, acute care, and mental health. | HIV |
| c | 2016 | USA | 33 female patients | Irregular migrant sex workers | HIV |
| d | 2016 | NETHERLANDS | 29 patients:19 females and 10 males | Patients from several settings and healthcare professionals; most respondents had a low or | ARTHRITIS |
| e | 2012 | UK | 43 HCPs, gender non-specified | Relevant due to its direct link to patient empowerment, covering a vast range of socio-cultural and economic backgrounds. The sample was formed by 43 hospital respiratory consultants, nurses, and general managers at 24 intervention and 11 control NCROP sites. | COPD and ASTHMA |
| f | 2009 | USA | 100 workshops, 2 organisations, and 5 managers | Psychologists working on human service organizations (non-profit, community-based organizations that provide social and health services to low-income individuals and families living in impoverished, urban communities.) | PATIENT |
| g | 2012 | USA | 20 patients: 14 males and 6 females | Racialised (African-American) men, historically discriminated, with low level of access and use of healthcare resources. Per capita and household incomes, as well as education, were discussed in the sample description. | PROSTATE |
| h | 2011 | UK | 42 patients: 27 females and 15 males | The paper reflected a wide variety of conditions and socio-cultural-economic backgrounds, as well as explicit vulnerability issues; e.g., persons diagnosed with severe mental disorders (*). | CHRONIC |
| i | 2012 | NEW ZEALAND | 26 female patients | Women with STI: human papilloma virus or genital herpes simplex virus (**). | VIRAL STI |
| j | 2017 | AUSTRALIA | Focused on | The paper included populations from rural settings (***) and from a diverse range of regions. | GENERAL HEALTH |
| k | 2008 | UK | 18 HCPs, without specifying gender; 2 general practitioners and 16 nurses; 17 patients (no gender specified) | The paper reflected a wide variety of conditions and social backgrounds. It included caregivers and caretakers with serious long-term illnesses (****). | PATIENT |
| l | 2013 | NETHERLANDS, UK | 14 researchers, 1 business officer and, 1 policy specialist; 16 patients: 9 females and 7 males | The paper reflected a wide variety of social backgrounds, and all patients suffered from chronic diseases coursing with complicated pain. (*). | PATIENT |
| m | 2015 | USA | 25 researchers | Eleven projects focused on largely African-American communities, nine focused on communities of mixed ethnicities, and five focused on immigrant or refugee populations and communities with lower access to healthcare. | COMMUNITIES |
| n | 2015 | GERMANY, USA | 20 female patients | Women with breast cancer and psychological vulnerability (*), including ethnic minorities, within a clinical trial (further information at | BREAST CANCER |
| o | 2014 | USA | 31 patients: 22 females and 9 males | This paper explicitly addressed communities and health disparities, including individuals from a diverse range of backgrounds, including ethnic minorities, different age groups, education, employment status, and income levels. | COMMUNITIES |
| p | 2009 | USA | 2 HCPs; 2 nurses, gender non-specified; 2 social workers; 10 key informants | 10 community-based organisations working on HIV prevention. | HIV |
| q | 2014 | UK | 38 researchers; 28 reports | Clinical trials. Chief investigators (CIs) and patient and public involvement (PPI) contributors were engaged; thus patients were from multiple sociocultural backgrounds, including dependent patients and caregivers (****). | PATIENT |
| r | 2015 | UK | 5 HCPs (gender non-specified); 1 researcher; 8 health-related professionals (e.g., public health, health promotion specialists, etc.); 3 patient representatives; 2 patients (gender non-specified; they seemed to be males); 8 organisations | Underrepresented communities, and voluntary or community organisations. | HIV |
| s | 2015 | NETHERLANDS | 13 researchers, 17 other officers (e.g., health funds); 7 public administration officers; 14 patient representatives; 9 reports considered | Maximum variation of participants was ensured in this study, including persons with some vulnerability conditions, such as intellectual disabilities. | DIVERSE CONDITIONS (cord injury; asthma; COPD; diabetes; neuromuscular diseases; renal failure; congenital heart disease; intellectual disabilities; burns) |
| t | 2016 | USA | 14 community members (genders non-specified) | Minority members of a community advisory board in AIDS/HIV research. | HIV, engagement, and CBPR |
| u | 2013 | NORWAY | 44 HCPs (gender non-specified); 13 public administration officers; 20 patients (gender non-specified) | Health professionals and patients participated in the study, which covered several backgrounds and, in particular, mental disorders (*). | PATIENT |
| v | 2017 | USA | 60 patients: 33 females and 27 males. | African-American males. Research was conducted in Alachua County, Florida: approximately 25% of the residents lived below the federal poverty level, and African-Americans comprised 20.5% of the population, and had the highest morbidity rates from chronic diseases. | PATIENT |
| x | 2016 | AUSTRALIA | 35 health workers (with HCPs being the vast majority) 31 of which were females; 6 aboriginal health workers; 2 allied health professionals; 6 nurses; 9 managers; 7 doctors; and 5 administrators | Aboriginal health. Health professionals from 2 urban and 1 regional Aboriginal Community Controlled Health Services (ACCHS) in New South Wales | COMMUNITIES |
(*) Mental disorders, and in particular highly stigmatised ones (e.g., borderline personality disorder (BPD)), were considered as a vulnerability condition, due to the systemic discrimination that these individuals may suffer, but also because of their lower access to resources. In parallel, mood disorders and important emotional disturbances linked to the chronic condition were considered within these conditions. (**) Sexually transmitted infections (STIs) were considered a vulnerability factor for accessing healthcare and for participating in the research due to the stigma linked to these conditions, mediated by gender expression and sex. (***) Rural populations were considered vulnerable because of the difficulties in accessing healthcare and health literacy, lack of infrastructure, and tele-communications challenges, among other potential difficulties, such as impoverished or deprived socio-economic circumstances. [3,4,5,6]. (****) Caregiving for dependent persons had a direct impact on the household financial burden, as well as very particular employment and workload challenges, while also mediated by other structural factors mainly related to age and gender [38,39,40].
Facilitators and barriers during design and recruitment.
|
|
|
Information prepared, adequate to the community and or individuals (l)(m)(q)(t), including cultural appropriateness (q)(s) Trust-building actions with the community or the participants (b)(i)(p)(r)(t) Strategies implemented for reducing power imbalance and tokenism (r)(s)(t) Ensured flexibility for participation integrated into the design from the beginning (i)(q)
Researchers able to involve the community from the design phase (l)(p)(q) |
|
Knowledge and competencies for implementing methods aimed at ensuring an active involvement, and participation of key persons and leaders (q)(s)(t)
Plan established for sharing results (p)(r)(t) Training foreseen or conducted for researchers in participatory research and co-production of healthcare innovation (p)(s)(t) Training foreseen or conducted for community members and participants involved (m)(p) | ||
|
|
Individual and personality factors that may undermine the participation, such as the lack of self-confidence (d)(q), or triggered by sensitive issues (i); fear of legal consequences (c)
Distrust of community leaders and civil society organisations (CSO) based on the fear of more stigmatisation and stereotyping (k)(p)(t) Disconnection between the community and the research entity (m)(p)(o) Lack of reimbursement for community organisations according to their workload (p)(t) Perceived lack of information and lack of transparency (t) Lack of long-term engagement and commitment with the community (m) Conflicting agendas between researchers and communities (p)(t) No training available or conducted for community members and participants (m)(p)
Conflicting agendas between researchers and communities (p)(t) Use of jargon, specialised terms, and, in general terms, non-adapted information (q) | |
|
Previous training conducted for researchers in co-production and participatory approaches (l)(q) Lack of leadership, support, and opportunities in the research institution (b)(q)
Administrative issues related to workload, allocation of resources (b)(l)(m)(q) Logistical problems in accessing the sample (q) Role conflicts in the same person researching; e.g., clinician and researcher (q) Unaffordable scientific demands such as deadlines, calls, or due dates (m) Lack of financial resources and strong dependency on funds by patients’ organisations (l) |
Facilitators and barriers during the engagement of participants and the co-production process.
|
|
|
Individuals encouraged for engaging in discussions, feeling confident to talk and explain their views (l)(q)(r)(s)(v)(e) Trust and rapport built between communities and researchers/institutions (p)(s)(x)(c) Safety, security, and anonymity (i)(c)(r)(v) Meaningful co-production, used for meeting community goals and needs (g)(p)(q) To feel as being heard, valued, and seen (u) To perceive empathy from the researchers (i) To give participants a sense of responsibility (v) To provide opportunity for producing shifts in thinking (e) To conduct collaborative efforts and deliberations (s)
Trust and rapport built between communities and researchers/institutions (p)(s)(x)(c) To provide opportunity for producing shifts in thinking (e) To conduct collaborative efforts and deliberations (s) |
|
Healthcare professionals actively involved (j)(p)(q)(r)(s) Possibilities for providing co-ownership or acknowledgement (l)(s)(u)(v) Clear expectations about the intervention (l)(p)(q) Terms adapted; e.g., in meetings, materials, questionnaires (l)(p)(x)
Organisations committed in their own internal policies to the research and/or the co-production process (r)(e) Budget, resources, time, and training available for the research team and the community involved (r)(e) Long-term financial and organisational support for the community (l)(p) To include capacity building in team-working skills (e) Financial transparency (m) Good reputation of the research institution (p)(v) Accessibility of materials, and performing adaptations if needed (l) | ||
|
|
Communication problems between communities/participants and researchers (i)(k)(l)(p)(q) Conflicting agendas between the research institution/researchers and the community leadership (k)(o)(p)(f)
Researchers viewed as outsiders by the participants (c)(o)(p)(r)(t)(v)(x) Lack of trust in the researchers (c)(o)(p)(t)(v) Community’s sense of “exploitation” perceived (p)(t)(x) Notable power imbalance between researchers and communities/individuals (p)(t) Emotionally charged communication and perceived intrusiveness regarding sensitive issues (i)(p) Lack of sense of community and cohesion (c)(o) Sensed ‘abandonment’ of a community/neighbourhood (o) Incompatibilities between the research and the socialisation environment (r)
Researchers’ technocratic approaches and tokenism (a)(f)(k)(l)(p)(q)(t) Perceived lack of rigour of the participatory approaches (j)(k)(l)(p) Suspected lack of neutrality of communities or advocacy groups (e.g., CSOs and patient associations) potentially considered as biased groups (p)(q)(s) Considerations in regards the role of lobbies, potentially biased (p) Political correctness perceived as a barrier to investigating by the researcher/s (p) Researchers’ lack of social skills (p) | |
|
Increased complexity and difficulties in working on co-production frameworks (e)(f)(q)
Logistic difficulties in attending meetings or interviews (f)(q)(r). Political barriers for obtaining funding (p)(f) Lack of administrative support for researchers (o)(p) Time and costs required for the recruitment (f) Unclear expectations from the point of view of the participants (l)(q) Burdensome demands in the research process, such as the duration and length of questionnaires (p)(r) Participants’ health conditions, limitations, and exacerbations (l) Language barriers (l) |
Figure A1Scheme reflecting the relation between the ladders of participation, the typology of the intervention and the social determinants of health in light of the communities’ engagement and empowerment. Prepared by the authors based on [16,42,43].
Figure 2Results discussed in light of the CEDI model.
Figure 3Checklist to promote community empowerment and individuals′ engagement in research for person-centred care.